|1.||Lin, Wun-Yuan: 1 article (10/2007)|
|2.||Hsu, Wei-Yi: 1 article (10/2007)|
|3.||Pan, Tzu-Ming: 1 article (10/2007)|
|4.||Hish, Chih-Hsuan: 1 article (10/2007)|
01/01/1994 - "It is assumed that the inhibition of tumor promotion by monascorubrin, chaetoviridin A and Monascus pigment is due to anti-inflammatory activity."
01/01/1994 - "Furthermore, monascorubrin (2 mumol), chaetoviridin A (2 mumol) and Monascus pigment (1 mg) markedly suppressed the promoting effect of TPA (1 microgram) on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene (50 micrograms). "
10/31/2007 - "Monascus secondary metabolites, including monacolin K, monascorubrin, and ankaflavin, have been reported to have an antiproliferative effect on cancer cells. "